Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Six Months Ended June 30, 2017	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	5,283,845		$	273,017		$	—		$	5,010,828
Less: Provision for uncollectible accounts	(228,468		)	(7,351		)	—			(221,117		)
Net patient service operating revenues	5,055,377			265,666			—			4,789,711
Capitated revenues	1,940,114			785,139			—			1,154,975
Other revenues	579,269			19,596			—			559,673
Total net operating revenues	7,574,760			1,070,401			—			6,504,359
Operating expenses	6,308,208			1,032,529			(232		)	5,275,911
Operating income	1,266,552			37,872			232			1,228,448
Debt expense, including refinancing charges	(212,391		)	(3,323		)	—			(209,068		)
Other income	9,496			151			—			9,345
Income tax expense	401,747			32,700			93			368,954
Net income	661,910			2,000			139			659,771
Less: Net income attributable to noncontrolling interests	(87,212		)	—			—			(87,212		)
Net income attributable to DaVita Inc.	$	574,698		$	2,000		$	139		$	572,559


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Six Months Ended June 30, 2017	Consolidated Total			Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	661,910		$	2,000	$	139	$	659,771
Other comprehensive income	62,333			—		—		62,333
Total comprehensive income	724,243			2,000		139		722,104
Less: Comprehensive income attributable to the noncontrolling interests	(87,210		)	—		—		(87,210		)
Comprehensive income attributable to DaVita Inc.	$	637,033		$	2,000	$	139	$	634,894


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of June 30, 2017	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	711,997	$	107,232	$	—	$	604,765
Accounts receivable, net	2,053,812		213,804		—		1,840,008
Other current assets	1,257,959		13,679		—		1,244,280
Total current assets	4,023,768		334,715		—		3,689,053
Property and equipment, net	3,248,030		3,368		—		3,244,662
Amortizable intangibles, net	1,462,894		4,553		—		1,458,341
Other long-term assets	717,301		82,477		2,946		631,878
Goodwill	9,889,791		29,865		—		9,859,926
Total assets	$	19,341,784	$	454,978	$	2,946	$	18,883,860
Current liabilities	$	2,773,325	$	178,259	$	—	$	2,595,066
Payables to parent	—		114,038		2,946		(116,984		)
Long-term debt and other long-term liabilities	10,286,859		55,870		—		10,230,989
Noncontrolling interests subject to put provisions	1,009,704		—		—		1,009,704
Total DaVita Inc. shareholders’ equity	5,084,314		106,811		—		4,977,503
Noncontrolling interests not subject to put provisions	187,582		—		—		187,582
Shareholders’ equity	5,271,896		106,811		—		5,165,085
Total liabilities and shareholder’s equity	$	19,341,784	$	454,978	$	2,946	$	18,883,860


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Six Months Ended June 30, 2017	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	661,910		$	2,000		$	139		$	659,771
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	349,534			(37,812		)	(139		)	387,485
Net cash provided by (used in) operating activities	1,011,444			(35,812		)	—			1,047,256
Cash flows from investing activities:
Additions of property and equipment	(398,940		)	(5,603		)	—			(393,337		)
Acquisitions and divestitures, net	(619,839		)	—			—			(619,839		)
Proceeds from discontinued operations	70,236			—			—			70,236
Investments and other items	96,895			(1,386		)	—			98,281
Net cash used in investing activities	(851,648		)	(6,989		)	—			(844,659		)
Cash flows from financing activities:
Long-term debt	(64,032		)	—			—			(64,032		)
Intercompany	—			45,342			—			(45,342		)
Other items	(301,146		)	—			—			(301,146		)
Net cash (used in) provided by financing activities	(365,178		)	45,342			—			(410,520		)
Effect of exchange rate changes on cash	4,192			—			—			4,192
Net (decrease) increase in cash	(201,190		)	2,541			—			(203,731		)
Cash and cash equivalents at beginning of period	913,187			104,691			—			808,496
Cash and cash equivalents at end of period	$	711,997		$	107,232		$	—		$	604,765


(1)	After elimination of the unrestricted subsidiaries and the physician groups.